Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
2002 26
2003 36
2004 43
2005 52
2006 32
2007 38
2008 35
2009 45
2010 34
2011 59
2012 43
2013 38
2014 42
2015 29
2016 46
2017 52
2018 39
2019 30
2020 31
2021 33
2022 15
Text availability
Article attribute
Article type
Publication date

Search Results

703 results
Results by year
Filters applied: . Clear all
Page 1
Management of severe osteoporosis.
Miller PD. Miller PD. Expert Opin Pharmacother. 2016;17(4):473-88. doi: 10.1517/14656566.2016.1124856. Epub 2015 Dec 23. Expert Opin Pharmacother. 2016. PMID: 26605922 Review.
Secondary and tertiary hyperparathyroidism.
Jamal SA, Miller PD. Jamal SA, et al. Among authors: miller pd. J Clin Densitom. 2013 Jan-Mar;16(1):64-8. doi: 10.1016/j.jocd.2012.11.012. Epub 2012 Dec 23. J Clin Densitom. 2013. PMID: 23267748 Review.
The future of canine glaucoma therapy.
Komáromy AM, Bras D, Esson DW, Fellman RL, Grozdanic SD, Kagemann L, Miller PE, Moroi SE, Plummer CE, Sapienza JS, Storey ES, Teixeira LB, Toris CB, Webb TR. Komáromy AM, et al. Among authors: miller pe. Vet Ophthalmol. 2019 Sep;22(5):726-740. doi: 10.1111/vop.12678. Epub 2019 May 20. Vet Ophthalmol. 2019. PMID: 31106969 Free PMC article. Review.
Engineering living therapeutics with synthetic biology.
Cubillos-Ruiz A, Guo T, Sokolovska A, Miller PF, Collins JJ, Lu TK, Lora JM. Cubillos-Ruiz A, et al. Among authors: miller pf. Nat Rev Drug Discov. 2021 Dec;20(12):941-960. doi: 10.1038/s41573-021-00285-3. Epub 2021 Oct 6. Nat Rev Drug Discov. 2021. PMID: 34616030 Review.
New mechanism underlying IL-31-induced atopic dermatitis.
Meng J, Moriyama M, Feld M, Buddenkotte J, Buhl T, Szöllösi A, Zhang J, Miller P, Ghetti A, Fischer M, Reeh PW, Shan C, Wang J, Steinhoff M. Meng J, et al. Among authors: miller p. J Allergy Clin Immunol. 2018 May;141(5):1677-1689.e8. doi: 10.1016/j.jaci.2017.12.1002. Epub 2018 Feb 7. J Allergy Clin Immunol. 2018. PMID: 29427643
Burosumab for the Treatment of Tumor-Induced Osteomalacia.
Jan de Beur SM, Miller PD, Weber TJ, Peacock M, Insogna K, Kumar R, Rauch F, Luca D, Cimms T, Roberts MS, San Martin J, Carpenter TO. Jan de Beur SM, et al. Among authors: miller pd. J Bone Miner Res. 2021 Apr;36(4):627-635. doi: 10.1002/jbmr.4233. Epub 2021 Jan 12. J Bone Miner Res. 2021. PMID: 33338281 Free PMC article. Clinical Trial.
Medical anti-glaucoma therapy: Beyond the drop.
Miller PE, Eaton JS. Miller PE, et al. Vet Ophthalmol. 2021 Mar;24 Suppl 1:2-15. doi: 10.1111/vop.12843. Epub 2020 Nov 9. Vet Ophthalmol. 2021. PMID: 33164328 Review.
Immunotherapy with engineered bacteria by targeting the STING pathway for anti-tumor immunity.
Leventhal DS, Sokolovska A, Li N, Plescia C, Kolodziej SA, Gallant CW, Christmas R, Gao JR, James MJ, Abin-Fuentes A, Momin M, Bergeron C, Fisher A, Miller PF, West KA, Lora JM. Leventhal DS, et al. Among authors: miller pf. Nat Commun. 2020 Jun 1;11(1):2739. doi: 10.1038/s41467-020-16602-0. Nat Commun. 2020. PMID: 32483165 Free PMC article.
703 results